|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:P05154 |
plasma serine protease inhibitor (human)
|
hSERPINA5
|
"A plasma serine protease inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05154]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053460 |
plasma serine protease inhibitor N-glycosylated 1 (human)
|
hSERPINA5/NGlyco:1
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G26271XI. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G26271XI." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053461 |
plasma serine protease inhibitor N-glycosylated 2 (human)
|
hSERPINA5/NGlyco:2
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G37399XV. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G37399XV." [GlyGen:P05154-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053462 |
plasma serine protease inhibitor N-glycosylated 3 (human)
|
hSERPINA5/NGlyco:3
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G41126SR. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G41126SR." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053463 |
plasma serine protease inhibitor N-glycosylated 4 (human)
|
hSERPINA5/NGlyco:4
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G60923RB. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G60923RB." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053464 |
plasma serine protease inhibitor N-glycosylated 5 (human)
|
hSERPINA5/NGlyco:5
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G87051GH. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G87051GH." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000053465 |
plasma serine protease inhibitor O-glycosylated 1 (human)
|
hSERPINA5/OGlyco:1
|
"A plasma serine protease inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-39 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05154-1, Thr-39, MOD:00005~GNO:G43417UB." [GlyGen:P05154-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000070093 |
plasma serine protease inhibitor, mature form (human)
|
hSERPINA5/mature
|
"A plasma serine protease inhibitor (human) that has had the signal peptide and propeptide removed. UniProtKB:P05154, 26-406." [PRO:DNx, Reactome:R-HSA-5591085]
|
|
|
|
|
|
